Background and Study Aims: After a first variceal bleeding episode in patients with cirrhosis of the liver, treatment with transjugular intrahepatic portosystemic stent shunt (TIPS) and endoscopic variceal ligation (EVL) plus propranolol were compared, with regard to prevention of variceal rebleeding, complications, and mortality. Patients and Methods: 85 patients were randomly allocated to receive TIPS (n = 43) or EVL (n = 42). The groups were comparable regarding age, sex, etiology of liver cirrhosis, and liver function. Results: The mean observation times were 4.1 years in the TIPS group and 3.6 years in the EVL group. Although the probability of rebleeding was higher in the EVL group (29.9 %) than in the TIPS group (19.4 %), the difference was not statistically significant. Three of five patients of the EVL group successfully underwent TIPS placement after treatment failure. The probability of TIPS dysfunction requiring shunt revision was 89 %. Hepatic encephalopathy was observed more often in the TIPS group (40.5 %) than in the EVL group (20.5 %; P < 0.05). The probability of survival was similar in both groups (TIPS group 75.9 %, EVL group 82.2 %; n.s.). Conclusions: In view of its good efficacy and the lower cost of treatment, endoscopic ligation plus propranolol may be recommended as initial procedure for prevention of recurrent variceal hemorrhage, whereas TIPS seems to be the preferable procedure in patients with recurrent bleeding after adequate endoscopic and pharmacological treatment.
References
1
Bosch J.
Medical treatment of portal hypertension.
Digestion.
1998;
59
547-555
4
Stiegmann G V, Goff J S, Michaletz-Onody P A. et al .
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.
N Engl J Med.
1992;
326
1521-1527
5
Laine L, Cook D.
Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis.
Ann Intern Med.
1995;
123
280-287
6
Sarin S K, Govil A, Jain A K. et al .
Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence.
J Hepatol.
1997;
26
826-832
7
Avgerinos A, Armonis A, Manolakopoulos S. et al .
Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study.
J Hepatol.
1997;
26
1034-1041
8
Baroncini D, Milandri G L, Borioni D. et al .
A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.
Endoscopy.
1997;
29
235-240
9
Sanyal A J, Freedman A M, Purdum P P. et al .
Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: A randomized prospective trial.
Ann Intern Med.
1997;
126
849-857
10
Cabrera J, Maynar M, Granados R. et al .
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.
Gastroenterology.
1996;
110
832-839
11
Cello J P, Ring E J, Olcott E W. et al .
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage.
Ann Intern Med.
1997;
126
858-865
12
Garcia-Villareal L, Martinez-Lagares F, Siebra A. et al .
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.
Hepatology.
1999;
29
27-32
13
Rössle M, Deibert P, Haag K. et al .
Randomised trial of transjugular intrahepatic portosystemic stent shunt versus endoscopy plus propranolol for variceal rebleeding.
Lancet.
1997;
349
1043-1049
14
Sauer P, Theilmann L, Stremmel W. et al .
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.
Gastroenterology.
1997;
113
1623-1631
15
Merli M, Salerno F, Riggio O. et al .
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T).
Hepatology.
1998;
27
48-53
16
Jalan R, Forrest E H, Stanley A J. et al .
A randomized trial comparing transjugular intrahepatic porto systemic stent shunt with variceal band ligation in the prevention of rebleeding from esophageal varices.
Hepatology.
1997;
26
1115-1122
17
Pomier-Layrargues G, Villeneuve J P, Deschenes M. et al .
Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: A randomised trial.
Gut.
2001;
48
390-396
18
Papatheodoridis G V, Goulis J, Leandro G. et al .
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.
Hepatology.
1999;
30
612-622
19
Luca A, D'Amico G, LaGalla R. et al .
TIPS for prevention of recurrent bleeding in patients with cirrhosis: A meta-analysis of randomized trials.
Radiology.
1999;
212
411-421
21
Richter G M, Noeldge G, Palmaz J C. et al .
Transjugular intrahepatic portocaval stent shunt. Preliminary clinical results.
Radiology.
1990;
174
1027-1030
24
Merkel M, Morabito A.
Adding beta-blockers to sclerotherapy in the prevention of variceal rebleeding. A meta-analysis assessment.
J Hepatol.
1994;
21
918-919
26
Lo G H, Lai K H, Cheng J S. et al .
Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: A prospective randomized trial.
Hepatology.
2000;
32
461-465
27
Merkel C, Bolognesi M, Sacerdoti D. et al .
The heodynamic response to medical treatment of portal hypertension as a predictor of clinical effectivness in the primary prophylaxis of variceal bleeding in cirrhosis.
Hepatology.
2000;
32
930-934
29
Lo G H, Lai K H, Cheng J S. et al .
The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: A prospective, randomized trial.
Hepatology.
1998;
28
391-395
30
Djurdjevic D, Janosevic S, Dapcevic B. et al .
Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: A randomized and prospective study.
Endoscopy.
1999;
31
286-290
31
Garg P K, Joshi Y K, Tandon R K.
Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: A prospective randomized study.
Gastrointest Endosc.
1999;
50
369-373
32
Saeed Z A, Stiegmann G V, Ramirez F C. et al .
Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: A multicenter prospective randomized trial.
Hepatology.
1997;
25
71-74
34 Pagliaro L, D'Amico G, Pasta L. et al .Portal hypertension in cirrhosis: Natural history. In: Bosch J, Groszmann R, editors Portal hypertension: Pathophysiology and treatment. Cambridge, MA; Blackwell Scientific 1994: 72-92
35
Roessle M, Haag K, Ochs A. et al .
The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.
N Engl J Med.
1994;
330
165-171
36
Lind C D, Malisch T W, Chong W K. et al .
Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement.
Gastroenterology.
1994;
106
1277-1283
37
Haskal Z J, Pentecost M J, Soulen M C. et al .
Transjugular intrahepatic portosystemic shunt stenosis and revision: Early and midterm results.
AJR Am J Roentgenol.
1994;
192
231-234
38
Sauer P, Theilmann L, Herrmann S. et al .
Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: A randomized trial.
Hepatology.
1996;
24
1433-1436
39
Richter G M, Noeldge G, Brado M. et al .
TIPSS: 10 years of clinical experience.
Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr.
1998;
168
307-315
